Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papillomavirus 18”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02188004
What this trial is testing

The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases

Who this might be right for
Human Papillomavirus InfectionGenital Warts
Jun Zhang 4,691
Not applicableUnknownNCT02411019
What this trial is testing

Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation

Who this might be right for
Cervical Intraepithelial Neoplasia 3
Genexine, Inc. 67
Testing effectiveness (Phase 2)Study completedNCT00263744
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of MEDI-517P in Healthy Adult Female Volunteers Who Are HPV-16 or HPV-18 DNA Positive

Who this might be right for
Healthy
MedImmune LLC 60
Post-approval studies (Phase 4)Study completedNCT01101750
What this trial is testing

Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?

Who this might be right for
Cervical CancerHpvWarts
Medstar Health Research Institute 25
Not applicableUnknownNCT05658198
What this trial is testing

Investigating HPV Vaccination Uptake in Adults Aged 18-35 Seeking Care at a Health Clinic in Rural Mississippi

Who this might be right for
Human Papillomavirus Vaccination
Plan A Health, Inc 100
Testing effectiveness (Phase 2)Looking for participantsNCT06319963
What this trial is testing

Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer

Who this might be right for
HPV-Related Cervical CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma
Theravectys S.A. 72
Not applicableActive Not RecruitingNCT06776055
What this trial is testing

Long-term Follow-up of Bivalent Human Papillomavirus (HPV) Vaccine Study in Women

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+2 more
Shanghai Zerun Biotechnology Co.,Ltd 5,372
Large-scale testing (Phase 3)Study completedNCT00834106
What this trial is testing

Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)

Who this might be right for
HPV Infections
Merck Sharp & Dohme LLC 3,006
Very early researchStudy completedNCT02546752
What this trial is testing

Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine

Who this might be right for
Human Papilloma Virus Infection Type 11Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18+2 more
Regenstrief Institute, Inc. 1,306
Post-approval studies (Phase 4)Looking for participantsNCT07668271
What this trial is testing

Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vaccine (Escherichia Coli)

Who this might be right for
Infection by Human Papilloma Virus
Xiamen Innovax Biotech Co., Ltd 720
Post-approval studies (Phase 4)Active Not RecruitingNCT07314307
What this trial is testing

Vaccine Effectiveness of One Dose of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Young-adult Women in Sweden Among Women Participating in a Clinical Trial of Concomitant HPV Vaccination and Screening

Who this might be right for
Incident HPV16, 18, 31, 33, 45, 52 or 58 Infection
Karolinska Institutet 150,000
Not applicableStudy completedNCT02551887
What this trial is testing

HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts

Who this might be right for
Human Papilloma Virus Infection Type 11Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18+4 more
Regenstrief Institute, Inc. 647
Testing effectiveness (Phase 2)UnknownNCT02710851
What this trial is testing

Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine

Who this might be right for
Condylomata Acuminata
Jun Zhang 640
Early research (Phase 1)Study completedNCT02405520
What this trial is testing

Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine

Who this might be right for
Condylomata Acuminata
Jun Zhang 145
Early research (Phase 1)Study completedNCT03813940
What this trial is testing

Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Who this might be right for
Condylomata AcuminataCervical Cancer
Xiamen University 24
Testing effectiveness (Phase 2)Study completedNCT01304524
What this trial is testing

VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Who this might be right for
Cervical Intraepithelial Neoplasia
Inovio Pharmaceuticals 167
Post-approval studies (Phase 4)Study completedNCT01424644
What this trial is testing

A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents

Who this might be right for
Meningococcal Meningitis
Novartis 801
Early research (Phase 1)Ended earlyNCT00798265
What this trial is testing

A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults

Who this might be right for
Human Immunodeficiency VirusHuman Papillomavirus- 6, 11, 16, 18Adolescent+1 more
National Cancer Institute (NCI) 26
Large-scale testing (Phase 3)Study completedNCT01381575
What this trial is testing

Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,447
Testing effectiveness (Phase 2)Study completedNCT00693966
What this trial is testing

Dose-Comparison Study to Evaluate the Safety and Immunogenicity of MEDI-517 (GSK 580299) in Healthy Adult Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 210
Next Page